Caris Life Sciences, Inc. (CAI)

31.76 +1.50 (+4.97%) USD  |  NASDAQ  |  Oct 15, 16:00
32.41 +0.65 (+2.05%) After-Hours: 04:35
More

Caris Life Sciences Cash from Operations (TTM) : 160.85M for June 30, 2026

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 160.85M
March 31, 2026 139.66M
December 31, 2025 75.44M
September 30, 2025 -0.546M
Date Value
June 30, 2025 -132.40M
March 31, 2025 -202.61M
December 31, 2024 -245.20M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
CareDx, Inc. 93.66M
Natera, Inc. 228.24M
Myriad Genetics, Inc. 7.70M
BioRestorative Therapies, Inc. -11.82M
Exagen, Inc. -6.498M